Global Human Oral Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
According to our (Global Info Research) latest study, the global Human Oral Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Human Oral Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Human Oral Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Oral Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Oral Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Oral Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Oral Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Oral Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, GSK, Sanofi, Lanzhou Institute and Serum Institute, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Human Oral Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Human Oral Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Oral Vaccine, with price, sales, revenue and global market share of Human Oral Vaccine from 2018 to 2023.
Chapter 3, the Human Oral Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Oral Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Human Oral Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Oral Vaccine.
Chapter 14 and 15, to describe Human Oral Vaccine sales channel, distributors, customers, research findings and conclusion.
According to our (Global Info Research) latest study, the global Human Oral Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Human Oral Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Human Oral Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Oral Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Oral Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Oral Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Oral Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Oral Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, GSK, Sanofi, Lanzhou Institute and Serum Institute, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Human Oral Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Rotavirus Vaccine
- Cholera Vaccine
- Oral Polio Vaccine
- Other
- Public
- Private
- Merck
- GSK
- Sanofi
- Lanzhou Institute
- Serum Institute
- Valneva
- Shanghai United Cell
- Bibcol
- PaxVax
- Vabiotech
- Tiantan Biological
- EuBiologics
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Human Oral Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Oral Vaccine, with price, sales, revenue and global market share of Human Oral Vaccine from 2018 to 2023.
Chapter 3, the Human Oral Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Oral Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Human Oral Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Oral Vaccine.
Chapter 14 and 15, to describe Human Oral Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Human Oral Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Oral Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Rotavirus Vaccine
1.3.3 Cholera Vaccine
1.3.4 Oral Polio Vaccine
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Oral Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Public
1.4.3 Private
1.5 Global Human Oral Vaccine Market Size & Forecast
1.5.1 Global Human Oral Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Human Oral Vaccine Sales Quantity (2018-2029)
1.5.3 Global Human Oral Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Human Oral Vaccine Product and Services
2.1.4 Merck Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Human Oral Vaccine Product and Services
2.2.4 GSK Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GSK Recent Developments/Updates
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Human Oral Vaccine Product and Services
2.3.4 Sanofi Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sanofi Recent Developments/Updates
2.4 Lanzhou Institute
2.4.1 Lanzhou Institute Details
2.4.2 Lanzhou Institute Major Business
2.4.3 Lanzhou Institute Human Oral Vaccine Product and Services
2.4.4 Lanzhou Institute Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Lanzhou Institute Recent Developments/Updates
2.5 Serum Institute
2.5.1 Serum Institute Details
2.5.2 Serum Institute Major Business
2.5.3 Serum Institute Human Oral Vaccine Product and Services
2.5.4 Serum Institute Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Serum Institute Recent Developments/Updates
2.6 Valneva
2.6.1 Valneva Details
2.6.2 Valneva Major Business
2.6.3 Valneva Human Oral Vaccine Product and Services
2.6.4 Valneva Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Valneva Recent Developments/Updates
2.7 Shanghai United Cell
2.7.1 Shanghai United Cell Details
2.7.2 Shanghai United Cell Major Business
2.7.3 Shanghai United Cell Human Oral Vaccine Product and Services
2.7.4 Shanghai United Cell Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Shanghai United Cell Recent Developments/Updates
2.8 Bibcol
2.8.1 Bibcol Details
2.8.2 Bibcol Major Business
2.8.3 Bibcol Human Oral Vaccine Product and Services
2.8.4 Bibcol Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bibcol Recent Developments/Updates
2.9 PaxVax
2.9.1 PaxVax Details
2.9.2 PaxVax Major Business
2.9.3 PaxVax Human Oral Vaccine Product and Services
2.9.4 PaxVax Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 PaxVax Recent Developments/Updates
2.10 Vabiotech
2.10.1 Vabiotech Details
2.10.2 Vabiotech Major Business
2.10.3 Vabiotech Human Oral Vaccine Product and Services
2.10.4 Vabiotech Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Vabiotech Recent Developments/Updates
2.11 Tiantan Biological
2.11.1 Tiantan Biological Details
2.11.2 Tiantan Biological Major Business
2.11.3 Tiantan Biological Human Oral Vaccine Product and Services
2.11.4 Tiantan Biological Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Tiantan Biological Recent Developments/Updates
2.12 EuBiologics
2.12.1 EuBiologics Details
2.12.2 EuBiologics Major Business
2.12.3 EuBiologics Human Oral Vaccine Product and Services
2.12.4 EuBiologics Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 EuBiologics Recent Developments/Updates
2.13 Panacea Biotec Ltd
2.13.1 Panacea Biotec Ltd Details
2.13.2 Panacea Biotec Ltd Major Business
2.13.3 Panacea Biotec Ltd Human Oral Vaccine Product and Services
2.13.4 Panacea Biotec Ltd Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Panacea Biotec Ltd Recent Developments/Updates
2.14 Bio-Med
2.14.1 Bio-Med Details
2.14.2 Bio-Med Major Business
2.14.3 Bio-Med Human Oral Vaccine Product and Services
2.14.4 Bio-Med Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Bio-Med Recent Developments/Updates
2.15 Halfkin Bio-Pharmaceuticals
2.15.1 Halfkin Bio-Pharmaceuticals Details
2.15.2 Halfkin Bio-Pharmaceuticals Major Business
2.15.3 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Product and Services
2.15.4 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HUMAN ORAL VACCINE BY MANUFACTURER
3.1 Global Human Oral Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Human Oral Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Human Oral Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Human Oral Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Human Oral Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Human Oral Vaccine Manufacturer Market Share in 2022
3.5 Human Oral Vaccine Market: Overall Company Footprint Analysis
3.5.1 Human Oral Vaccine Market: Region Footprint
3.5.2 Human Oral Vaccine Market: Company Product Type Footprint
3.5.3 Human Oral Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Human Oral Vaccine Market Size by Region
4.1.1 Global Human Oral Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Human Oral Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Human Oral Vaccine Average Price by Region (2018-2029)
4.2 North America Human Oral Vaccine Consumption Value (2018-2029)
4.3 Europe Human Oral Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Human Oral Vaccine Consumption Value (2018-2029)
4.5 South America Human Oral Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Human Oral Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Human Oral Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Human Oral Vaccine Consumption Value by Type (2018-2029)
5.3 Global Human Oral Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Human Oral Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Human Oral Vaccine Consumption Value by Application (2018-2029)
6.3 Global Human Oral Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Human Oral Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Human Oral Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Human Oral Vaccine Market Size by Country
7.3.1 North America Human Oral Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Human Oral Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Human Oral Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Human Oral Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Human Oral Vaccine Market Size by Country
8.3.1 Europe Human Oral Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Human Oral Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Human Oral Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Human Oral Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Human Oral Vaccine Market Size by Region
9.3.1 Asia-Pacific Human Oral Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Human Oral Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Human Oral Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Human Oral Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Human Oral Vaccine Market Size by Country
10.3.1 South America Human Oral Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Human Oral Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Human Oral Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Human Oral Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Human Oral Vaccine Market Size by Country
11.3.1 Middle East & Africa Human Oral Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Human Oral Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Human Oral Vaccine Market Drivers
12.2 Human Oral Vaccine Market Restraints
12.3 Human Oral Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Human Oral Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Oral Vaccine
13.3 Human Oral Vaccine Production Process
13.4 Human Oral Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Oral Vaccine Typical Distributors
14.3 Human Oral Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Human Oral Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Oral Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Rotavirus Vaccine
1.3.3 Cholera Vaccine
1.3.4 Oral Polio Vaccine
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Oral Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Public
1.4.3 Private
1.5 Global Human Oral Vaccine Market Size & Forecast
1.5.1 Global Human Oral Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Human Oral Vaccine Sales Quantity (2018-2029)
1.5.3 Global Human Oral Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Human Oral Vaccine Product and Services
2.1.4 Merck Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Human Oral Vaccine Product and Services
2.2.4 GSK Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GSK Recent Developments/Updates
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Human Oral Vaccine Product and Services
2.3.4 Sanofi Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sanofi Recent Developments/Updates
2.4 Lanzhou Institute
2.4.1 Lanzhou Institute Details
2.4.2 Lanzhou Institute Major Business
2.4.3 Lanzhou Institute Human Oral Vaccine Product and Services
2.4.4 Lanzhou Institute Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Lanzhou Institute Recent Developments/Updates
2.5 Serum Institute
2.5.1 Serum Institute Details
2.5.2 Serum Institute Major Business
2.5.3 Serum Institute Human Oral Vaccine Product and Services
2.5.4 Serum Institute Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Serum Institute Recent Developments/Updates
2.6 Valneva
2.6.1 Valneva Details
2.6.2 Valneva Major Business
2.6.3 Valneva Human Oral Vaccine Product and Services
2.6.4 Valneva Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Valneva Recent Developments/Updates
2.7 Shanghai United Cell
2.7.1 Shanghai United Cell Details
2.7.2 Shanghai United Cell Major Business
2.7.3 Shanghai United Cell Human Oral Vaccine Product and Services
2.7.4 Shanghai United Cell Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Shanghai United Cell Recent Developments/Updates
2.8 Bibcol
2.8.1 Bibcol Details
2.8.2 Bibcol Major Business
2.8.3 Bibcol Human Oral Vaccine Product and Services
2.8.4 Bibcol Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bibcol Recent Developments/Updates
2.9 PaxVax
2.9.1 PaxVax Details
2.9.2 PaxVax Major Business
2.9.3 PaxVax Human Oral Vaccine Product and Services
2.9.4 PaxVax Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 PaxVax Recent Developments/Updates
2.10 Vabiotech
2.10.1 Vabiotech Details
2.10.2 Vabiotech Major Business
2.10.3 Vabiotech Human Oral Vaccine Product and Services
2.10.4 Vabiotech Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Vabiotech Recent Developments/Updates
2.11 Tiantan Biological
2.11.1 Tiantan Biological Details
2.11.2 Tiantan Biological Major Business
2.11.3 Tiantan Biological Human Oral Vaccine Product and Services
2.11.4 Tiantan Biological Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Tiantan Biological Recent Developments/Updates
2.12 EuBiologics
2.12.1 EuBiologics Details
2.12.2 EuBiologics Major Business
2.12.3 EuBiologics Human Oral Vaccine Product and Services
2.12.4 EuBiologics Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 EuBiologics Recent Developments/Updates
2.13 Panacea Biotec Ltd
2.13.1 Panacea Biotec Ltd Details
2.13.2 Panacea Biotec Ltd Major Business
2.13.3 Panacea Biotec Ltd Human Oral Vaccine Product and Services
2.13.4 Panacea Biotec Ltd Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Panacea Biotec Ltd Recent Developments/Updates
2.14 Bio-Med
2.14.1 Bio-Med Details
2.14.2 Bio-Med Major Business
2.14.3 Bio-Med Human Oral Vaccine Product and Services
2.14.4 Bio-Med Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Bio-Med Recent Developments/Updates
2.15 Halfkin Bio-Pharmaceuticals
2.15.1 Halfkin Bio-Pharmaceuticals Details
2.15.2 Halfkin Bio-Pharmaceuticals Major Business
2.15.3 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Product and Services
2.15.4 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HUMAN ORAL VACCINE BY MANUFACTURER
3.1 Global Human Oral Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Human Oral Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Human Oral Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Human Oral Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Human Oral Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Human Oral Vaccine Manufacturer Market Share in 2022
3.5 Human Oral Vaccine Market: Overall Company Footprint Analysis
3.5.1 Human Oral Vaccine Market: Region Footprint
3.5.2 Human Oral Vaccine Market: Company Product Type Footprint
3.5.3 Human Oral Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Human Oral Vaccine Market Size by Region
4.1.1 Global Human Oral Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Human Oral Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Human Oral Vaccine Average Price by Region (2018-2029)
4.2 North America Human Oral Vaccine Consumption Value (2018-2029)
4.3 Europe Human Oral Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Human Oral Vaccine Consumption Value (2018-2029)
4.5 South America Human Oral Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Human Oral Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Human Oral Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Human Oral Vaccine Consumption Value by Type (2018-2029)
5.3 Global Human Oral Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Human Oral Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Human Oral Vaccine Consumption Value by Application (2018-2029)
6.3 Global Human Oral Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Human Oral Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Human Oral Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Human Oral Vaccine Market Size by Country
7.3.1 North America Human Oral Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Human Oral Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Human Oral Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Human Oral Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Human Oral Vaccine Market Size by Country
8.3.1 Europe Human Oral Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Human Oral Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Human Oral Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Human Oral Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Human Oral Vaccine Market Size by Region
9.3.1 Asia-Pacific Human Oral Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Human Oral Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Human Oral Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Human Oral Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Human Oral Vaccine Market Size by Country
10.3.1 South America Human Oral Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Human Oral Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Human Oral Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Human Oral Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Human Oral Vaccine Market Size by Country
11.3.1 Middle East & Africa Human Oral Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Human Oral Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Human Oral Vaccine Market Drivers
12.2 Human Oral Vaccine Market Restraints
12.3 Human Oral Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Human Oral Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Oral Vaccine
13.3 Human Oral Vaccine Production Process
13.4 Human Oral Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Oral Vaccine Typical Distributors
14.3 Human Oral Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Human Oral Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Human Oral Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Human Oral Vaccine Product and Services
Table 6. Merck Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Recent Developments/Updates
Table 8. GSK Basic Information, Manufacturing Base and Competitors
Table 9. GSK Major Business
Table 10. GSK Human Oral Vaccine Product and Services
Table 11. GSK Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. GSK Recent Developments/Updates
Table 13. Sanofi Basic Information, Manufacturing Base and Competitors
Table 14. Sanofi Major Business
Table 15. Sanofi Human Oral Vaccine Product and Services
Table 16. Sanofi Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Sanofi Recent Developments/Updates
Table 18. Lanzhou Institute Basic Information, Manufacturing Base and Competitors
Table 19. Lanzhou Institute Major Business
Table 20. Lanzhou Institute Human Oral Vaccine Product and Services
Table 21. Lanzhou Institute Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Lanzhou Institute Recent Developments/Updates
Table 23. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 24. Serum Institute Major Business
Table 25. Serum Institute Human Oral Vaccine Product and Services
Table 26. Serum Institute Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Serum Institute Recent Developments/Updates
Table 28. Valneva Basic Information, Manufacturing Base and Competitors
Table 29. Valneva Major Business
Table 30. Valneva Human Oral Vaccine Product and Services
Table 31. Valneva Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Valneva Recent Developments/Updates
Table 33. Shanghai United Cell Basic Information, Manufacturing Base and Competitors
Table 34. Shanghai United Cell Major Business
Table 35. Shanghai United Cell Human Oral Vaccine Product and Services
Table 36. Shanghai United Cell Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Shanghai United Cell Recent Developments/Updates
Table 38. Bibcol Basic Information, Manufacturing Base and Competitors
Table 39. Bibcol Major Business
Table 40. Bibcol Human Oral Vaccine Product and Services
Table 41. Bibcol Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Bibcol Recent Developments/Updates
Table 43. PaxVax Basic Information, Manufacturing Base and Competitors
Table 44. PaxVax Major Business
Table 45. PaxVax Human Oral Vaccine Product and Services
Table 46. PaxVax Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. PaxVax Recent Developments/Updates
Table 48. Vabiotech Basic Information, Manufacturing Base and Competitors
Table 49. Vabiotech Major Business
Table 50. Vabiotech Human Oral Vaccine Product and Services
Table 51. Vabiotech Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Vabiotech Recent Developments/Updates
Table 53. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 54. Tiantan Biological Major Business
Table 55. Tiantan Biological Human Oral Vaccine Product and Services
Table 56. Tiantan Biological Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Tiantan Biological Recent Developments/Updates
Table 58. EuBiologics Basic Information, Manufacturing Base and Competitors
Table 59. EuBiologics Major Business
Table 60. EuBiologics Human Oral Vaccine Product and Services
Table 61. EuBiologics Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. EuBiologics Recent Developments/Updates
Table 63. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 64. Panacea Biotec Ltd Major Business
Table 65. Panacea Biotec Ltd Human Oral Vaccine Product and Services
Table 66. Panacea Biotec Ltd Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Panacea Biotec Ltd Recent Developments/Updates
Table 68. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 69. Bio-Med Major Business
Table 70. Bio-Med Human Oral Vaccine Product and Services
Table 71. Bio-Med Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Bio-Med Recent Developments/Updates
Table 73. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Halfkin Bio-Pharmaceuticals Major Business
Table 75. Halfkin Bio-Pharmaceuticals Human Oral Vaccine Product and Services
Table 76. Halfkin Bio-Pharmaceuticals Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 78. Global Human Oral Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Human Oral Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Human Oral Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Human Oral Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Human Oral Vaccine Production Site of Key Manufacturer
Table 83. Human Oral Vaccine Market: Company Product Type Footprint
Table 84. Human Oral Vaccine Market: Company Product Application Footprint
Table 85. Human Oral Vaccine New Market Entrants and Barriers to Market Entry
Table 86. Human Oral Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Human Oral Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Human Oral Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Human Oral Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Human Oral Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Human Oral Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Human Oral Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Human Oral Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Human Oral Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Human Oral Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Human Oral Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Human Oral Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Human Oral Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Human Oral Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Human Oral Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Human Oral Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Human Oral Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Human Oral Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Human Oral Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Human Oral Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Human Oral Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Human Oral Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Human Oral Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Human Oral Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Human Oral Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Human Oral Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Human Oral Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Human Oral Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Human Oral Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Human Oral Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Human Oral Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Human Oral Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Human Oral Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Human Oral Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Human Oral Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Human Oral Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Human Oral Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Human Oral Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Human Oral Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Human Oral Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Human Oral Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Human Oral Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Human Oral Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Human Oral Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Human Oral Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Human Oral Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Human Oral Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Human Oral Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Human Oral Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Human Oral Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Human Oral Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Human Oral Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Human Oral Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Human Oral Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Human Oral Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Human Oral Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Human Oral Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Human Oral Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Human Oral Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Human Oral Vaccine Raw Material
Table 146. Key Manufacturers of Human Oral Vaccine Raw Materials
Table 147. Human Oral Vaccine Typical Distributors
Table 148. Human Oral Vaccine Typical Customers
Table 1. Global Human Oral Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Human Oral Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Human Oral Vaccine Product and Services
Table 6. Merck Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Recent Developments/Updates
Table 8. GSK Basic Information, Manufacturing Base and Competitors
Table 9. GSK Major Business
Table 10. GSK Human Oral Vaccine Product and Services
Table 11. GSK Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. GSK Recent Developments/Updates
Table 13. Sanofi Basic Information, Manufacturing Base and Competitors
Table 14. Sanofi Major Business
Table 15. Sanofi Human Oral Vaccine Product and Services
Table 16. Sanofi Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Sanofi Recent Developments/Updates
Table 18. Lanzhou Institute Basic Information, Manufacturing Base and Competitors
Table 19. Lanzhou Institute Major Business
Table 20. Lanzhou Institute Human Oral Vaccine Product and Services
Table 21. Lanzhou Institute Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Lanzhou Institute Recent Developments/Updates
Table 23. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 24. Serum Institute Major Business
Table 25. Serum Institute Human Oral Vaccine Product and Services
Table 26. Serum Institute Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Serum Institute Recent Developments/Updates
Table 28. Valneva Basic Information, Manufacturing Base and Competitors
Table 29. Valneva Major Business
Table 30. Valneva Human Oral Vaccine Product and Services
Table 31. Valneva Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Valneva Recent Developments/Updates
Table 33. Shanghai United Cell Basic Information, Manufacturing Base and Competitors
Table 34. Shanghai United Cell Major Business
Table 35. Shanghai United Cell Human Oral Vaccine Product and Services
Table 36. Shanghai United Cell Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Shanghai United Cell Recent Developments/Updates
Table 38. Bibcol Basic Information, Manufacturing Base and Competitors
Table 39. Bibcol Major Business
Table 40. Bibcol Human Oral Vaccine Product and Services
Table 41. Bibcol Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Bibcol Recent Developments/Updates
Table 43. PaxVax Basic Information, Manufacturing Base and Competitors
Table 44. PaxVax Major Business
Table 45. PaxVax Human Oral Vaccine Product and Services
Table 46. PaxVax Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. PaxVax Recent Developments/Updates
Table 48. Vabiotech Basic Information, Manufacturing Base and Competitors
Table 49. Vabiotech Major Business
Table 50. Vabiotech Human Oral Vaccine Product and Services
Table 51. Vabiotech Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Vabiotech Recent Developments/Updates
Table 53. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 54. Tiantan Biological Major Business
Table 55. Tiantan Biological Human Oral Vaccine Product and Services
Table 56. Tiantan Biological Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Tiantan Biological Recent Developments/Updates
Table 58. EuBiologics Basic Information, Manufacturing Base and Competitors
Table 59. EuBiologics Major Business
Table 60. EuBiologics Human Oral Vaccine Product and Services
Table 61. EuBiologics Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. EuBiologics Recent Developments/Updates
Table 63. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 64. Panacea Biotec Ltd Major Business
Table 65. Panacea Biotec Ltd Human Oral Vaccine Product and Services
Table 66. Panacea Biotec Ltd Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Panacea Biotec Ltd Recent Developments/Updates
Table 68. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 69. Bio-Med Major Business
Table 70. Bio-Med Human Oral Vaccine Product and Services
Table 71. Bio-Med Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Bio-Med Recent Developments/Updates
Table 73. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Halfkin Bio-Pharmaceuticals Major Business
Table 75. Halfkin Bio-Pharmaceuticals Human Oral Vaccine Product and Services
Table 76. Halfkin Bio-Pharmaceuticals Human Oral Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 78. Global Human Oral Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Human Oral Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Human Oral Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Human Oral Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Human Oral Vaccine Production Site of Key Manufacturer
Table 83. Human Oral Vaccine Market: Company Product Type Footprint
Table 84. Human Oral Vaccine Market: Company Product Application Footprint
Table 85. Human Oral Vaccine New Market Entrants and Barriers to Market Entry
Table 86. Human Oral Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Human Oral Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Human Oral Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Human Oral Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Human Oral Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Human Oral Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Human Oral Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Human Oral Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Human Oral Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Human Oral Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Human Oral Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Human Oral Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Human Oral Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Human Oral Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Human Oral Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Human Oral Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Human Oral Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Human Oral Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Human Oral Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Human Oral Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Human Oral Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Human Oral Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Human Oral Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Human Oral Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Human Oral Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Human Oral Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Human Oral Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Human Oral Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Human Oral Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Human Oral Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Human Oral Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Human Oral Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Human Oral Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Human Oral Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Human Oral Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Human Oral Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Human Oral Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Human Oral Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Human Oral Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Human Oral Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Human Oral Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Human Oral Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Human Oral Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Human Oral Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Human Oral Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Human Oral Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Human Oral Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Human Oral Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Human Oral Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Human Oral Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Human Oral Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Human Oral Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Human Oral Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Human Oral Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Human Oral Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Human Oral Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Human Oral Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Human Oral Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Human Oral Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Human Oral Vaccine Raw Material
Table 146. Key Manufacturers of Human Oral Vaccine Raw Materials
Table 147. Human Oral Vaccine Typical Distributors
Table 148. Human Oral Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Human Oral Vaccine Picture
Figure 2. Global Human Oral Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Human Oral Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Rotavirus Vaccine Examples
Figure 5. Cholera Vaccine Examples
Figure 6. Oral Polio Vaccine Examples
Figure 7. Other Examples
Figure 8. Global Human Oral Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Human Oral Vaccine Consumption Value Market Share by Application in 2022
Figure 10. Public Examples
Figure 11. Private Examples
Figure 12. Global Human Oral Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Human Oral Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Human Oral Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Human Oral Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Human Oral Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Human Oral Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Human Oral Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Human Oral Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Human Oral Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Human Oral Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Human Oral Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Human Oral Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Human Oral Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Human Oral Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Human Oral Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Human Oral Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Human Oral Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Human Oral Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Human Oral Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Human Oral Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Human Oral Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Human Oral Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Human Oral Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Human Oral Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Human Oral Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Human Oral Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Human Oral Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Human Oral Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Human Oral Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Human Oral Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Human Oral Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Human Oral Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Human Oral Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Human Oral Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 54. China Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Human Oral Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Human Oral Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Human Oral Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Human Oral Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Human Oral Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Human Oral Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Human Oral Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Human Oral Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Human Oral Vaccine Market Drivers
Figure 75. Human Oral Vaccine Market Restraints
Figure 76. Human Oral Vaccine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Human Oral Vaccine in 2022
Figure 79. Manufacturing Process Analysis of Human Oral Vaccine
Figure 80. Human Oral Vaccine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Human Oral Vaccine Picture
Figure 2. Global Human Oral Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Human Oral Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Rotavirus Vaccine Examples
Figure 5. Cholera Vaccine Examples
Figure 6. Oral Polio Vaccine Examples
Figure 7. Other Examples
Figure 8. Global Human Oral Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Human Oral Vaccine Consumption Value Market Share by Application in 2022
Figure 10. Public Examples
Figure 11. Private Examples
Figure 12. Global Human Oral Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Human Oral Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Human Oral Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Human Oral Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Human Oral Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Human Oral Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Human Oral Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Human Oral Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Human Oral Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Human Oral Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Human Oral Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Human Oral Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Human Oral Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Human Oral Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Human Oral Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Human Oral Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Human Oral Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Human Oral Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Human Oral Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Human Oral Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Human Oral Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Human Oral Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Human Oral Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Human Oral Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Human Oral Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Human Oral Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Human Oral Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Human Oral Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Human Oral Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Human Oral Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Human Oral Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Human Oral Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Human Oral Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Human Oral Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 54. China Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Human Oral Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Human Oral Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Human Oral Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Human Oral Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Human Oral Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Human Oral Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Human Oral Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Human Oral Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Human Oral Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Human Oral Vaccine Market Drivers
Figure 75. Human Oral Vaccine Market Restraints
Figure 76. Human Oral Vaccine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Human Oral Vaccine in 2022
Figure 79. Manufacturing Process Analysis of Human Oral Vaccine
Figure 80. Human Oral Vaccine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
